SCHEMBL96584

SCHEMBL96584

O=CCCCCOc1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR4 O95977 5/20 0.55
▸ TDP1 Q9NUW8 3/20 0.54
▸ MAPT P10636 2/20 0.54
▸ RAB9A P51151 3/20 0.52
▸ HPGD P15428 4/20 0.50
▸ TSHR P16473 4/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ NLRP1 Q9C000 1/20 0.49
▸ MAPK1 P28482 3/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ MAOB P27338 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6613233 0.95 S1PR4 (0.56) S1PR4TDP1MAPTRAB9AHPGD
SCHEMBL11090540 0.90 S1PR4 (0.57) S1PR4TDP1MAPTRAB9AHPGD
SCHEMBL98231 0.85 ALDH1A1 (0.54) S1PR4TDP1MAPTRAB9ATSHR
SCHEMBL9214093 0.80 MAPT (0.57) S1PR4TDP1MAPTRAB9AHPGD
SCHEMBL11413525 0.80 S1PR4 (0.66) S1PR4TDP1MAPT
SCHEMBL3736949 0.79 TDP1 (0.56) S1PR4TDP1MAPTRAB9AHPGD
SCHEMBL22557984 0.79 KDM4E (0.57) MAPTRAB9AHPGDTSHRNPC1
SCHEMBL7237501 0.78 MAPT (0.58) S1PR4TDP1MAPTRAB9AHPGD
SCHEMBL10727219 0.77 MAPK1 (0.62) S1PR4TDP1MAPTRAB9AHPGD
SCHEMBL1283086 0.77 MAPT (0.58) S1PR4TDP1MAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 — — US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 — — EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 — — EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 — — US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 — — US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 — — US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 — — US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 — — EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB S1PR4 3698/4885TDP1 3588/4885MAPT 4112/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 S1PR4 754/4885TDP1 4079/4885MAPT 4773/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 S1PR4 754/4885TDP1 4079/4885MAPT 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback